Indirect Pulp Capping With Resin Modified Glass Ionomer
Launched by UNIVERSIDADE FEDERAL DE SERGIPE · Jul 7, 2015
Trial Information
Current as of August 11, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Molars and pre-molars presenting carious lesions involving 2/3 inner of dentin tissue.
- Exclusion Criteria:
- • Teeth presenting signs of irreversible pulpits or necrose, cervical lesion and/or root exposition, or with carious lesion reaching the pulp.
About Universidade Federal De Sergipe
The Universidade Federal de Sergipe (UFS) is a prominent public educational institution in Brazil, dedicated to advancing research and innovation in the health sciences. As a clinical trial sponsor, UFS is committed to conducting high-quality research that adheres to ethical standards and regulatory requirements. The university's diverse team of researchers and healthcare professionals collaborates to explore new treatments and interventions, aiming to improve patient outcomes and contribute valuable knowledge to the scientific community. UFS emphasizes a multidisciplinary approach, fostering partnerships with national and international institutions to enhance the impact and reach of its clinical studies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Aracaju, Se, Brazil
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials